8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 23, 2021

GENETHERA, INC.

(Exact name of registrant as specified in its charter)

Nevada	000-27237	65-0622463
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

3051 W 105th Ave. Westminster, CO	80031
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (720) 587-5100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions.  

☐   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act   (17 CFR 240.14d-2(b))  

☐   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act   (17 CFR 240.13e-4(c))  

 1

ITEM 10.1 GENETHERA, INC. INCORPORATES SUBSIDIARY IN THE UNITED KINGDOM

On April 23, 2021 GeneThera Inc. received confirmation from The Registrar of Companies for England and Wales that GeneThera’s subsidiary, GeneThera Robotics Limited., has been registered in the United Kingdom. The ownership of the subsidiary is designated as followed: GeneThera Inc fifty-one percentage; Alejandra Baglietto forty-nine percentage. On the same day GeneThera Board of Directors approved the appointment of Mrs. Alejandra Baglietto as Managing Director of GeneThera Robotics Ltd. GeneThera Inc subsidiary will be responsible for the UK and International operations related to the development of the Zoonotic Infectious Diseases Alert Shield (ZIDAS) platform. Mrs. Baglietto holds a B.A. and M.A. from Cal State University at San Bernardino. She has worked both in the private and public sector and has experience dealing with government and business relations, clients, communications and investments. Mrs. Baglietto has worked with numerous private and public companies, most recently, assisting with assessing political risk, international trade investments and ministry of finance guarantees. 

Item 9.01 EXHIBITS

Exhibit Number Description

10.1 Incorporation Documents

. Exhibit A

Exhibit B

 2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

GeneThera, Inc.,

a Nevada Corporation

By:/s/ Antonio Milici

Antonio Milici, CEO

Date: May 18, 2021

 3

EX-10.1

Exhibit 10.1

CERTIFICATE OF INCORPORATION

OF A

PRIVATE LIMITED COMPANY

Company Number 13353473

The Registrar of Companies for England and Wales, hereby certifies that

GENETHERA ROBOTICS LIMITED

is this day incorporated under the Companies Act 2006 as a private company, that the company is limited by shares, and the situation of its registered office is in England and Wales.

Given at Companies House, Cardiff, on 23rd April 2021.

The above information was communicated by electronic means and authenticated by the

Registrar of Companies under section 1115 of the Companies Act 2006 

	CS01(ef)
	Confirmation Statement

Company Name:	GENETHERA ROBOTICS LIMITED
Company Number:	13353473
Received for filing in Electronic Format on the: 04/05/2021

Company Name:	GENETHERA ROBOTICS LIMITED
Company Number:	13353473
Confirmation Statement date:	04/05/2021

Electronically filed document for Company Number: 13353473

Full details of Shareholders

The details below relate to individuals/corporate bodies that were shareholders during the review period or that had ceased to be shareholders since the date of the previous confirmation statement.

Shareholder information for a non-traded company as at the confirmation statement date is shown below

Shareholding 1:	49000000 ORDINARY shares held as at the date of this confirmation statement
Name:	ALEJANDRA BAGLIETTO
Shareholding 2:	51000000 ORDINARY shares held as at the date of this confirmation statement
Name:	GENETHERA, INC

Electronically filed document for Company Number: 13353473

Confirmation Statement

I confirm that all information required to be delivered by the company to the registrar in relation to the confirmation period concerned either has been delivered or is being delivered at the same time as the confirmation statement

Electronically filed document for Company Number: 13353473

Authorisation

Authenticated

This form was authorised by one of the following:

Director, Secretary, Person Authorised, Charity Commission Receiver and Manager, CIC Manager, Judicial Factor

Electronically filed document for Company Number: 13353473